- In September 2024, The Company announced the completion of its acquisition of BIOVECTRA, enhancing its contract development and manufacturing capabilities. This move expanded Agilent's CDMO services and supported gene editing, reflecting its commitment to advancing therapeutics programs with best-in-class manufacturing
- In July 2021, STARLIMS Corporation had signed a definitive agreement with Francisco Partners for the STARLIMS informatics product suite and related business assets from Abbott. This partnership will further help the company to get well positioned for continued growth in the competitive market
- In April 2023, Microsoft and Epic has expanded their partnership to integrate generative AI into healthcare, leveraging Azure OpenAI Service with Epic's EHR software. This collaboration aims to boost productivity, enhance patient care, and improve the financial integrity of health systems worldwide
- In October 2024, Xybion has launched LIMS 10.0, a modern, AI-enabled solution enhancing lab efficiency across industries. Featuring an intuitive interface, integrated QMS, and robust functionalities like inventory management and audit trails, it transforms laboratory operations and accelerates compliance and throughput globally
- In On September 2024, LabVantage Solutions partnered with Henkel to create an integrated R&D platform, connecting LabVantage LIMS and SAP PLM. This collaboration aimed to streamline processes, enhance data sharing, and drive digital transformation in Henkel’s consumer brands division
